CoChat

Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease

Open access
Meyersohn, Nandini M., Mayrhofer, Thomas, Corey, Kathleen E., Bittner, Daniel O., Staziaki, Pedro V., Szilveszter, Balint, Hallett, Travis, Lu, Michael T., Puchner, Stefan B., Simon, Tracey G., Foldyna, Borek, Voora, Deepak, Ginsburg, Geoffrey S., Douglas, Pamela S., Hoffmann, Udo, Ferencik, Maros · 2021 · Clinical Gastroenterology and Hepatology
Cited by 105

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Background & Aims: Hepatic steatosis has been associated with increased risk of major adverse cardiovascular events (MACE) but it is not clear whether steatosis is independently associated with risk of MACE. We investigated whether steatosis is associated with risk of MACE independently of the presence and extent of baseline coronary artery disease, assessed by comprehensive contrast-enhanced computed tomography angiography (CTA). Methods: We conducted a nested cohort study of 3756 subjects (mean age, 60.6 years; 48.4% men) who underwent coronary CTA at 193 sites in North America, from July 2010 through September 2013, as part of the PROMISE study, which included noninvasive cardiovascular analyses of symptomatic outpatients without coronary artery disease. Independent core laboratory readers measured hepatic and splenic attenuation, using non-contrast computed tomography images to identify steatosis, and evaluated coronary plaques and stenosis in coronary CTA images. We collected data on participants’ cardiovascular risk factors, presence of metabolic syndrome, and body mass index. The primary endpoint was an adjudicated composite of MACE (death, myocardial infarction, or unstable angina) during a median follow-up time of 25 months. Results: Among the 959 subjects who had steatosis (25.5% of the cohort), 42 had MACE (4.4%), whereas among the 2797 subjects without steatosis, 73 had MACE (2.6%) (hazard ratio [HR] for MACE in subjects with steatosis, 1.69; 95% CI, 1.16–2.48; P=.006 for MACE in subjects with vs without steatosis). This association remained after adjustment for atherosclerotic cardiovascular disease risk scores, significant stenosis, and metabolic syndrome (adjusted HR, 1.72; 95% CI, 1.16–2.54; P=.007) or obesity (adjusted HR, 1.75; 95% CI, 1.19–2.59; P=.005). Steatosis remained independently associated with MACE after adjustment for all CTA measures of plaques and stenosis. Conclusions: Hepatic steatosis is associated with MACE independently of other cardiovascular risk factors or extent of coronary artery disease. Strategies to reduce steatosis might reduce risk of MACE. ClinicalTrials.gov no: NCT01174550

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cgh.2020.07.030

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 105

Metadata

Authors
Meyersohn, N. M., Mayrhofer, T., Corey, K. E., Bittner, D. O., Staziaki, P. V., Szilveszter, B., Hallett, T., Lu, M. T., Puchner, S. B., Simon, T. G., Foldyna, B., Voora, D., Ginsburg, G. S., Douglas, P. S., Hoffmann, U., & Ferencik, M.
Venue
Clinical Gastroenterology and Hepatology
Publisher
Elsevier BV
Published
2021-07
Volume
19
Issue
7
Pages
1480-1488.e14
ISSN
1542-3565 (ISSN-L)
OpenAlex
W3044625573
Cited by
105
References
10
FWCI
8.29
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. https://app.cochat.ai/papers/10.1016/j.cgh.2020.07.030
The paper
Meyersohn, N. M., Mayrhofer, T., Corey, K. E., Bittner, D. O., Staziaki, P. V., Szilveszter, B., Hallett, T., Lu, M. T., Puchner, S. B., Simon, T. G., Foldyna, B., Voora, D., Ginsburg, G. S., Douglas, P. S., Hoffmann, U., & Ferencik, M. (2021). Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2020.07.030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.